Industries > Pharma > Global Vascular Grafts Market Report 2019-2029

Global Vascular Grafts Market Report 2019-2029

Analysis by Indication (EVAR, Abdominal Aneurysm Repair, Thoracic), Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic), End-User (Hospital, Ambulatory Surgery Center), Company, Global Opportunity Analysis by Country and Industry Forecast

PUBLISHED: 07 June 2019
PAGES: 158
PRODUCT CODE: PHA0436
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0436 Categories: , Tag:

Market Definition:
• Vascular grafts are medical devices used to bypass the infected or diseased blood vessels.
• Vascular grafts are required to replace injured blood vessels, veins, and arteries and to substitute hard blood vessels or valves.
• Vascular Grafts are mainly used in treatment of cardiovascular diseases by surgical procedures such as bypass grafting. The graft is taken from the patient’s body and surgically inserted at the required site to bypass the damaged or diseased blood vessels.

Market Overview and Trends
• Increasing incidence of cardiac diseases, diabetes, End Stage Renal Disease (ESRD), and vascular occlusions is the major factor responsible for market growth.
• Increase in geriatric population, technological advancements, and changes in life style (consumption of junk food, tobacco, and alcohol) are also expected to boost the market growth.
• Rising pervasiveness of cardiovascular diseases and aortic aneurysms coupled with chronic kidney disease will boost market growth during the foreseeable future.

Market Dynamics:

Factors Influencing the Market Growth:
• Rise in incidence of vascular disorders, high blood sugar, hypertension, and other risk factors that lead to blockage of blood vessels drive the growth of the vascular grafts market
• Sedentary lifestyle and unhealthy eating habits are also expected to boost the product demand over the forecast period.

Factors Restraining the Market Growth:
• Low reimbursement and high out-of-pocket expenditure in emerging economies may restrict the market growth to some extent.

Market Segmentation 2019-2029:
The Vascular Grafts market is segmented on the Indication, Raw Material, End User, and geography

1. Vascular Grafts Market, By Indication
a. EVAR
b. Abdominal
c. Thoracic

2. Vascular Grafts Market, By Raw Material
a. Polyester
b. ePTFE
c. Polyurethane
d. Biosynthetic

3. Vascular Grafts Market, By End User
a. Hospital
b. Ambulatory Surgery Center

4. Vascular Grafts Market, By Region
4.1 Introduction
4.2 North America
4.2.1 US
4.2.2 Canada
4.3 Europe
4.3.1 Germany
4.3.2 UK
4.3.3 France
4.3.4 Rest of Europe
4.4 Asia Pacific
4.4.1 Japan
4.4.2 China
4.4.3 India
4.4.4 Rest of Asia Pacific
4.5 Rest of the World (RoW)

Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Vascular Grafts market.
• These companies has developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.

Major Market Players:
• Medtronic, plc; LeMaitre Vascular Inc.; Terumo Corp.; Getinge AB; W.L. Gore and Associates, Inc.; and Cook Medical, Inc amongst others

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Vascular Grafts Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Vascular Grafts Market Report 2019-2029


Latest Pharma news

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019

READ

“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019

READ

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

READ

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

READ

Categories

Category